Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.
Sun
Wan-Ling
WL
Köck
Leonhard
L
Walder
Alois
A
Erdel
Martin
M
Kilga-Nogler
Susanne
S
Schennach
Harald
H
Fiegl
Michael
M
D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D000077269:Lenalidomide; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D013792:Thalidomide; D000077269:Lenalidomide; D008775:Methylprednisolone